Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more
The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology. … Read more
Researchers from the Department of Breast Surgery at Fudan University Shanghai Cancer Center and the Department of Oncology at Shanghai Medical College, Fudan University have developed a new classification system for breast cancer based on the cancer-immunity cycle (CIC). Published in Cancer Biology & Medicine in 2026, this framework uses a “CIC score” to categorize … Read more
Researchers at McMaster University have developed a new immunotherapy strategy that simultaneously attacks glioblastoma tumors and the immune cells that help them grow. By using Chimeric Antigen Receptor T-cell (CAR-T) therapy to target the GPNMB protein, the study—published July 1 in Nature—demonstrated the ability to eliminate detectable tumors and achieve long-term disease-free survival in pre-clinical … Read more
Researchers at Southern Medical University have identified that Bifidobacterium animalis, a common probiotic, secretes mannose to boost the effectiveness of melanoma immunotherapy. According to a study published in the May 2026 issue of Cancer Biology & Medicine, this sugar activates CD8⁺ T cells by targeting the Hippo-YAP1 signaling pathway, offering a potential new strategy to … Read more
Unmasking the Body’s Hidden Defense Against Melanoma For years, medical science has focused heavily on T cells and B cells in the fight against cancer. However, groundbreaking research from the Garvan Institute of Medical Research has shifted the spotlight toward an unlikely hero: the macrophage. Often dismissed as mere “housekeepers” of the immune system, these … Read more
Breakthrough in Cancer Immunotherapy: How a Tiny Fraction of T Cells Could Revolutionize Multiple Myeloma Treatment By [Your Name], Cancer Immunotherapy Research Journalist Osaka, Japan — A groundbreaking study from researchers at Osaka University has uncovered a surprising truth about how the body fights cancer: in the battle against multiple myeloma, only a small group … Read more
Beyond Blood Cancers: The New Frontier of Solid Tumor Therapy For years, CAR-T cell therapy has been hailed as a miracle for certain blood cancers, but solid tumors—particularly aggressive brain cancers like glioblastoma—have remained stubbornly resistant. The challenge isn’t just the cancer itself, but the “shield” these tumors build around themselves to hide from the … Read more
The Neuroimmune Frontier: Redefining How We Fight Lung Cancer For decades, the battle against lung cancer has focused primarily on two fronts: attacking the tumor directly and boosting the immune system to recognize and destroy malignant cells. However, a groundbreaking discovery from the Francis Crick Institute suggests we have been missing a critical piece of … Read more
The Hidden Trigger: How Gut Bacteria Drive Colon Cancer For years, the medical community has tracked a troubling link between the common gut bacterium Bacteroides fragilis and the formation of colon tumors. We knew this bacterium secreted a toxin—known as BFT—that damaged the colon’s lining, potentially paving the way for colorectal cancer. However, the “how” … Read more